Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: A case control study

Infectious Agents and Cancer

Volumn 4, Issue SUPPL. 1, 2009, Pages

  Okobia, Michael N ^a,b,c   Bunker, Clareann H ^a   Garte, Seymour J ^a   Zmuda, Joseph M ^a   Ezeome, Emmanuel R ^d   Anyanwu, Stanley N C ^e   Uche, Emmanuel E O ^f   Osime, Usifo ^c   Ojukwu, Joseph ^d   Kuller, Lewis H ^a   Ferrell, Robert E ^a   Taioli, Emanuela ^a,b,g  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF BENIN   (Nigeria)

^d UNIVERSITY OF NIGERIA   (Nigeria)

^e NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^f UNIVERSITY OF PORT HARCOURT   (Nigeria)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1B1;

ADULT; BREAST CANCER; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NIGERIA; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNIVERSITY HOSPITAL;

EID: 60349095031     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-4-S1-S12     Document Type: Conference Paper

References (38)

1. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. TR Sutter YM Tang CL Hayes YY Wo EW Jabs X Li H Yin CW Cody WF Greenlee, Journal Biol Chem 1994 269 18 13092 13099 8175734
2. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. YM Tang YY Wo J Stewart AL Hawkins CA Griffin TR Sutter WF Greenlee, J Biol Chem 1996 271 45 28324 28330 10.1074/jbc.271.45.28341 8910454
3. Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. I Stoilov AN Akarsu I Alozie A Child M Barsoum-Homsy ME Turacli M Or RA Lewis N Ozdemir G Brice, Am J Hum Genet 1998 62 3 573 584 9497261 10.1086/301764
4. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. LR Bailey N Roodi WD Dupont FF Parl, Cancer Res 1998 58 22 5038 5041 9823305
5. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. CL Hayes DC Spink BC Spink JQ Cao NJ Walker TR Sutter, Proc Natl Acad Sci USA 1996 93 18 9776 9781 8790407 10.1073/pnas.93.18.9776
6. Functional role of estrogen metabolism in target cells: review and perspectives. BT Zhu AH Conney, Carcinogenesis 1998 19 1 1 27 10.1093/carcin/19.1.1 9472688
7. Carcinogenicity of catechol estrogens in Syrian hamsters. JG Liehr WF Fang DA Sirbasku A Ari-Ulubelen, J Steroid Biochem 1986 24 1 353 356 10.1016/0022-4731(86)90080-4 3009986
8. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. EL Cavalieri DE Stack PD Devanesan R Todorovic I Dwivedy S Higginbotham SL Johansson KD Patil ML Gross JK Gooden, Proc Natl Acad Sci USA 1997 94 20 10937 10942 9380738 10.1073/pnas.94.20.10937
9. Association of CYP1B1 polymorphisms and breast cancer risk. I De Vivo SE Hankinson L Li GA Colditz DJ Hunter, Cancer Epidemiol Biomarkers Prev 2002 11 5 489 492 12010864
10. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk. T Rylander-Rudqvist S Wedren F Granath K Humphreys S Ahlberg E Weiderpass M Oscarson M Ingelman-Sundberg I Persson, Carcinogenesis 2003 24 9 1533 1539 10.1093/carcin/bgg114 12844487
11. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. J Listgarten S Damaraju B Poulin L Cook J Dufour A Driga J Mackey D Wishart R Greiner B Zanke, Clin Cancer Res 2004 10 8 2725 2737 10.1158/1078-0432.CCR-1115-03 15102677
12. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. AM Dunning M Dowsett CS Healey L Tee RN Luben E Folkerd KL Novik L Kelemen S Ogata PD Pharoah, J Natl Cancer Inst 2004 96 12 936 945 15199113
13. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. NA Kocabas S Sardas S Cholerton AK Daly AE Karakaya, Arch Toxicol 2002 76 11 643 649 10.1007/s00204-002-0387-x 12415427
14. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. TC Zimarina VN Kristensen EN Imianitov LM Bershtein, Molekuliarnaia biologiia 2004 38 3 386 393 15285606
15. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. W Wen Q Cai XO Shu JR Cheng F Parl L Pierce YT Gao W Zheng, Cancer Epidemiol Biomarkers Prev 2005 14 2 329 335 10.1158/1055-9965.EPI-04-0392 15734954
16. Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. KM Lee J Abel Y Ko V Harth WY Park JS Seo KY Yoo JY Choi A Shin SH Ahn, Br J Cancer 2003 88 5 675 678 10.1038/sj.bjc.6600761 12618873
17. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. J Watanabe T Shimada EM Gillam T Ikuta K Suemasu Y Higashi O Gotoh K Kawajiri, Pharmacogenetics 2000 10 1 25 33 10.1097/00008571-200002000-00004 10739169
18. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. W Zheng DW Xie F Jin JR Cheng Q Dai WQ Wen XO Shu YT Gao, Cancer Epidemiol Biomarkers Prev 2000 9 2 147 150 10698474
19. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women. M Okobia C Bunker J Zmuda C Kammerer V Vogel E Uche S Anyanwu E Ezeome R Ferrell L Kuller, Breast Cancer Res Treat 2005 94 3 285 293 10.1007/s10549-005-9022-x 16254684
20. Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women. MN Okobia CH Bunker JM Zmuda ER Ezeome SN Anyanwu EE Uche J Ojukwu LH Kuller RE Ferrell, J Carcinog 2006 5 12 16684355 10.1186/1477-3163-5-12
21. Case-control study of risk factors for breast cancer in Nigerian women. M Okobia C Bunker J Zmuda C Kammerer V Vogel E Uche S Anyanwu E Ezeome R Ferrell L Kuller, Int J Cancer 2006 119 9 2179 2185 10.1002/ijc.22102 16823837
22. Anthropometry and breast cancer risk in nigerian women. MN Okobia CH Bunker JM Zmuda U Osime ER Ezeome SN Anyanwu EE Uche J Ojukwu LH Kuller, Breast J 2006 12 5 462 466 10.1111/j.1075-122X.2006.00304.x 16958966
23. The effect of a low fat diet on estrogen metabolism. C Longcope S Gorbach B Goldin M Woods J Dwyer A Morrill J Warram, J Clin Endocrinol Metab 1987 64 6 1246 1250 3571427
24. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review. V Paracchini S Raimondi IT Gram D Kang NA Kocabas VN Kristensen D Li FF Parl T Rylander-Rudqvist P Soucek, Am J Epidemiol 2007 165 2 115 125 10.1093/aje/kwj365 17053044
25. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. J Zhu P Chang ML Bondy AA Sahin SE Singletary S Takahashi T Shirai D Li, Cancer Epidemiol Biomarkers Prev 2003 12 9 830 837 14504191
26. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study. B Thyagarajan M Brott P Mink AR Folsom KE Anderson WS Oetting M Gross, Cancer Lett 2004 207 2 183 189 10.1016/j.canlet. 2003.12.009 15072827
27. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. L Le Marchand T Donlon LN Kolonel BE Henderson LR Wilkens, Cancer Epidemiol Biomarkers Prev 2005 14 8 1998 2003 10.1158/1055-9965.EPI-05-0076 16103451
28. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. T Shimada CL Hayes H Yamazaki S Amin SS Hecht FP Guengerich TR Sutter, Cancer Res 1996 56 13 2979 2984 8674051
29. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. DC Spink HP Eugster DW Lincoln 2nd JD Schuetz EG Schuetz JA Johnson LS Kaminsky JF Gierthy, Arch Biochem Biophys 1992 293 2 342 348 10.1016/0003-9861(92)90404-K 1536570
30. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. DC Spink CL Hayes NR Young M Christou TR Sutter CR Jefcoate JF Gierthy, J Steroid Biochem Mol Biol 1994 51 5-6 251 258 10.1016/0960-0760(94)90037-X 7826886
31. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. JJ Li SA Li, Fed Proc 1987 46 5 1858 1863 3030825
32. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. X Han JG Liehr, Carcinogenesis 1995 16 10 2571 2574 10.1093/carcin/16.10.2571 7586168
33. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. X Han JG Liehr, Carcinogenesis 1994 15 5 997 1000 10.1093/carcin/15.5.997 8200107
34. 4-Hydroxylation of estrogens as marker of human mammary tumors. JG Liehr MJ Ricci, Proc Natl Acad Sci USA 1996 93 8 3294 3296 8622931 10.1073/pnas.93.8.3294
35. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 2 74 108 15761078
36. Estimating the world cancer burden: Globocan 2000. DM Parkin F Bray J Ferlay P Pisani, Int J Cancer 2001 94 2 153 156 10.1002/ijc.1440 11668491
37. Breast cancer in eastern Nigeria: a ten year review. SN Anyanwu, West Afr J Med 2000 19 2 120 125 11070747
38. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. OF Ikpatt R Ndoma-Egba, Cent Afr J Med 2003 49 11-12 122 126 15301464